Sort
30,917 grants matching “tumor microenvironment”
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$516,975Marco Ruella · University Of Pennsylvania · R37 · FY2023 · CA
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
$516,900Shiaowen David Hsu · Duke University · U01 · FY2021 · CA
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
$516,873Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · CA
Molecular Oncology Training Program
$516,863Dawn Hershman · Columbia University Health Sciences · T32 · FY2023 · CA
Investigating mechanisms of bladder cancer metastasis
$516,846Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA
Investigating mechanisms of bladder cancer metastasis
$516,846Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2023 · CA
Investigating mechanisms of bladder cancer metastasis
$516,846Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2024 · CA
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
$516,840Zachary Conrad Hartman · Duke University · R01 · FY2023 · CA
Translational Immunology
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$516,726Gordon B. Mills · Oregon Health & Science University · U01 · FY2023 · CA
Elucidating the mechanisms that are responsible for the stability of cancer cell state
$516,592Barry H Honig · Columbia University Health Sciences · U54 · FY2018 · CA
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
$516,548Barry Ian Hudson · Georgetown University · R01 · FY2023 · CA
Advancing allogeneic CAR-iNKT for the treatment of solid tumors through comparative oncology
$516,527Nicola J Mason · University Of Pennsylvania · U01 · FY2022 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$516,407Gordon B. Mills · Oregon Health & Science University · U01 · FY2022 · CA
Core 3: Mouse Models Core (MM Core)
$516,360Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2023 · CA
Targeting Ferritin in Glioblastoma
$516,320Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Nanoparticles-mediated combination therapy for breast cancer
$516,189Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Project 2: Cell Migration in Mechanically Complex Microenvironments
$516,070Paolo Provenzano · University Of Minnesota · U54 · FY2017 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$516,038Scott Andrew Gerber · University Of Rochester · R01 · FY2021 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$516,038Scott Andrew Gerber · University Of Rochester · R01 · FY2022 · CA
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
$516,032Mark A Anastasio · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Chuan-Yuan Li · Duke University · R01 · FY2022 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2023 · CA
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression
$515,907Dan Theodorescu · Cedars-Sinai Medical Center · P01 · FY2024 · CA
Non-neoplastic cell types dictate gliomagenesis and
$515,843Dolores Hambardzumyan · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · CA